背景:耐药结核病(DR-TB)的传播正在进行中。寻找DR-TB患者并尽早开始治疗对于改善患者临床结果和打破传播链以控制大流行非常重要。据我们所知,评估有效性的系统评价,成本效益,可接受性,以及为DR-TB提供不同病例发现策略的可行性,政策,并且没有进行实践,目前还不清楚是否有足够的研究来进行这样的审查。目前尚不清楚DR-TB和药物敏感性TB的病例发现策略是否相似,以及我们是否可以利用药物敏感性审查的结果来指导DR-TB病例发现策略的决策。
目的:本方案旨在描述关于DR-TB病例发现的现有文献,并描述病例发现策略。
方法:我们将筛选系统综述,试验,定性研究,诊断测试准确性研究,以及其他专门寻求改善DR-TB病例检测的主要研究。我们将排除邀请个人寻求结核病症状治疗的研究,那些包括已经被诊断患有结核病的人,或基于实验室的研究。我们将搜索包括MEDLINE在内的学术数据库,Embase,科克伦图书馆,非洲信息,CINAHL,认识论,和PROSPERO,没有语言或日期限制。我们将筛选标题,摘要,和全文一式两份。将使用Excel(MicrosoftCorp)进行数据提取和分析。
结果:我们将提供带有支持数字或表格的叙述性报告,以总结数据。基于系统的逻辑模型,从药物敏感结核病的病例发现策略的综合发展,将用作描述不同策略的框架,由此产生的途径,和路径的增强。搜索将于2021年底进行。标题和摘要筛选,全文筛选,数据提取将于2022年1月至6月进行。此后,将进行分析,和结果汇编。
结论:这项范围审查将绘制有关DR-TB病例发现的现有文献-这将有助于确定有效性的初步研究成本效益,可接受性,以及存在不同的DR-TB病例发现策略的可行性,这将有助于为系统审查制定潜在的问题。我们还将描述DR-TB的病例发现策略,以及它们如何适合药物易感TB的病例发现途径模型。本综述有一定的局限性。一个限制是多样性,文献中干预术语的使用不一致,这可能会导致相关研究的缺失。对干预策略的不良报告也可能导致对干预措施的误解和错误分类。最后,针对DR-TB的病例发现策略可能不适合根据药物敏感TB策略开发的模型。然而,这种情况将为今后的研究提供一个完善模型的机会。审查将指导进一步的研究,为DR-TB的病例发现政策和实践提供信息。
UNASSIGNED:DERR1-10.2196/40009。
BACKGROUND: Transmission of drug-resistant tuberculosis (DR-TB) is ongoing. Finding individuals with DR-TB and initiating treatment as early as possible is important to improve patient clinical outcomes and to break the chain of transmission to control the pandemic. To our knowledge systematic reviews assessing effectiveness, cost-effectiveness,
acceptability, and feasibility of different
case-finding strategies for DR-TB to inform research, policy, and practice have not been conducted, and it is unknown whether enough research exists to conduct such reviews. It is unknown whether case-finding strategies are similar for DR-TB and drug-susceptible TB and whether we can draw on findings from drug-susceptible reviews to inform decisions on case-finding strategies for DR-TB.
OBJECTIVE: This protocol aims to describe the available literature on case-finding for DR-TB and to describe
case-finding strategies.
METHODS: We will screen systematic reviews, trials, qualitative studies, diagnostic test accuracy studies, and other primary research that specifically sought to improve DR-TB case detection. We will exclude studies that invited individuals seeking care for TB symptoms, those including individuals already diagnosed with TB, or laboratory-based studies. We will search the academic databases including MEDLINE, Embase, The Cochrane Library, Africa-Wide Information, CINAHL, Epistemonikos, and PROSPERO with no language or date restrictions. We will screen titles, abstracts, and full-text articles in duplicate. Data extraction and analyses will be performed using Excel (Microsoft Corp).
RESULTS: We will provide a narrative report with supporting figures or tables to summarize the data. A systems-based logic model, developed from a synthesis of case-finding strategies for drug-susceptible TB, will be used as a framework to describe different strategies, resulting pathways, and enhancements of pathways. The search will be conducted at the end of 2021. Title and abstract screening, full text screening, and data extraction will be undertaken from January to June 2022. Thereafter, analysis will be conducted, and results compiled.
CONCLUSIONS: This scoping review will chart existing literature on case-finding for DR-TB-this will help determine whether primary studies on effectiveness, cost-effectiveness,
acceptability, and feasibility of different case-finding strategies for DR-TB exist and will help formulate potential questions for a systematic review. We will also describe
case-finding strategies for DR-TB and how they fit into a model of
case-finding pathways for drug-susceptible TB. This review has some limitations. One limitation is the diverse, inconsistent use of intervention terminology within the literature, which may result in missing relevant studies. Poor reporting of intervention strategies may also cause misunderstanding and misclassification of interventions. Lastly, case-finding strategies for DR-TB may not fit into a model developed from strategies for drug-susceptible TB. Nevertheless, such a situation will provide an opportunity to refine the model for future research. The review will guide further research to inform decisions on case-finding policies and practices for DR-TB.
UNASSIGNED: DERR1-10.2196/40009.